mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.003 |
mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.003 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.003 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.006 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.007 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.008 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.008 |